Rodney Mood

Rodney Mood is an experienced professional in business development and technology management within the healthcare sector. As the Head of Business Development RWE at RetinAI since May 2025, Mood focuses on integrating machine learning and medical imaging to enhance patient care in ophthalmology. Previous roles include Director of Business Development at Verana Health, where Mood contributed to building the largest clinical databases in medicine, and Director of Business Development at Clinetic, emphasizing real-world evidence in research. Mood co-founded Epividian, Inc., serving as Chief Operating Officer while also holding leadership positions at Takeda, Crispin Corp., GlaxoSmithKline, Plurimus, and HealthMatics. Educational background includes an MBA in Entrepreneurship & Technology Commercialization from North Carolina State University and a B.S. in Computer Science from Purdue University.